Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms"

Assessment of the impact of the use of durvalumab for the treatment of advanced small cell lung cancer on the achievement of the target "reduction in mortality from neoplasms"

Aim. Impact evaluation of effective methods for advanced small cell lung cancer treatment using the drug durvalumab on the achievement of the Russian Federation national and regional programs Healthcare Development target indicator reduction of mortality from neoplasms. Materials and methods. The...

Full description

Bibliographic Details
Main Authors: Vasilii V. Ryazhenov, Sergey V. Orlov, Oksana I. Ivakhnenko
Format: Article
Language:Russian
Published: IP Habib O.N. 2022-04-01
Series:Современная онкология
Subjects:
neoplasms mortality
lung cancer
durvalumab
national program “healthcare development“
Online Access:https://modernonco.orscience.ru/1815-1434/article/viewFile/106790/81180

Internet

https://modernonco.orscience.ru/1815-1434/article/viewFile/106790/81180

Similar Items